APO Research
Talk to an analyst

APO RESEARCH · REPORT

Embolization Particle

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Selected research

Industry Growth & Trends

Global Embolization Particle Industry Growth and Trends Forecast to 2032

26 December 202598 pages

Choose your research edition.

Industry ResearchEmbolization Particle Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Embolization Particle Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Embolization Particle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Embolization Particle Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Embolization Particle Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Embolization Particle market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Embolization Particle market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Embolization Particle market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Embolization Particle.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Embolization Particle market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Embolization Particle Market by Company

Sirtex Medical

Merit Medical

Cook Medical

BTG Medical

Boston Scientific Corporation

Terumo Corporation

HENGRUI Medical

INterface BIOmaterials B.V.

Alicon

Embolization Particle Segment by Type

Microspheres

Particles (e.g. PVA Particles, Gelfoam Particles)

Drug-eluting Beads (DEBs)

Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Embolization Particle Segment by Application

Uterine Fibroid Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Liver Tumor Embolization

Trauma Embolization

Others

Embolization Particle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Microspheres Table 2. Major Company of Particles (e.g. PVA Particles, Gelfoam Particles) Table 3. Major Company of Drug-eluting Beads (DEBs) Table 4. Major Company of Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Table 5. Global Embolization Particle Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Embolization Particle Sales by Type (2021-2026) & (K Units) Table 7. Global Embolization Particle Sales Market Share in Volume by Type (2021-2026) Table 8. Global Embolization Particle Sales by Type (2021-2026) & (US$ Million) Table 9. Global Embolization Particle Sales Market Share in Value by Type (2021-2026) Table 10. Global Embolization Particle Price by Type (2021-2026) & (USD/Unit) Table 11. Global Embolization Particle Sales by Type (2027-2032) & (K Units) Table 12. Global Embolization Particle Sales Market Share in Volume by Type (2027-2032) Table 13. Global Embolization Particle Sales by Type (2027-2032) & (US$ Million) Table 14. Global Embolization Particle Sales Market Share in Value by Type (2027-2032) Table 15. Global Embolization Particle Price by Type (2027-2032) & (USD/Unit) Table 16. North America Embolization Particle Sales by Type (2021-2026) & (K Units) Table 17. North America Embolization Particle Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Embolization Particle Sales by Type (2021-2026) & (K Units) Table 19. Europe Embolization Particle Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Embolization Particle Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Embolization Particle Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Embolization Particle Sales by Type (2021-2026) & (K Units) Table 23. Latin America Embolization Particle Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Embolization Particle Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Embolization Particle Sales by Type (2021-2026) & (US$ Million) Table 26. Embolization Particle Industry Trends Table 27. Embolization Particle Industry Drivers Table 28. Embolization Particle Industry Opportunities and Challenges Table 29. Embolization Particle Industry Restraints Table 30. Global Embolization Particle Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Embolization Particle Revenue Market Share by Company (2021-2026) Table 32. Global Embolization Particle Sales by Company (2021-2026) & (K Units) Table 33. Global Embolization Particle Sales Share by Company (2021-2026) Table 34. Global Embolization Particle Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Embolization Particle Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Embolization Particle Major Company Production Sites and Headquarters Table 37. Global Embolization Particle Company, Product Type & Application Table 38. Global Embolization Particle Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Embolization Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Embolization Particle Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Embolization Particle Sales by Region (2021-2026) & (K Units) Table 43. Global Embolization Particle Sales Market Share in Volume by Region (2021-2026) Table 44. Global Embolization Particle Sales by Region (2021-2026) & (US$ Million) Table 45. Global Embolization Particle Sales Market Share in Value by Region (2021-2026) Table 46. Global Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Embolization Particle Sales by Region (2027-2032) & (K Units) Table 48. Global Embolization Particle Sales Market Share in Volume by Region (2027-2032) Table 49. Global Embolization Particle Sales by Region (2027-2032) & (US$ Million) Table 50. Global Embolization Particle Sales Market Share in Value by Region (2027-2032) Table 51. Global Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Embolization Particle Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Embolization Particle Sales by Application (2021-2026) & (K Units) Table 54. Global Embolization Particle Sales Market Share in Volume by Application (2021-2026) Table 55. Global Embolization Particle Sales by Application (2021-2026) & (US$ Million) Table 56. Global Embolization Particle Sales Market Share in Value by Application (2021-2026) Table 57. Global Embolization Particle Price by Application (2021-2026) & (USD/Unit) Table 58. Global Embolization Particle Sales by Application (2027-2032) & (K Units) Table 59. Global Embolization Particle Sales Market Share in Volume by Application (2027-2032) Table 60. Global Embolization Particle Sales by Application (2027-2032) & (US$ Million) Table 61. Global Embolization Particle Sales Market Share in Value by Application (2027-2032) Table 62. Global Embolization Particle Price by Application (2027-2032) & (USD/Unit) Table 63. North America Embolization Particle Sales by Application (2021-2026) & (K Units) Table 64. North America Embolization Particle Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Embolization Particle Sales by Application (2021-2026) & (K Units) Table 66. Europe Embolization Particle Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Embolization Particle Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Embolization Particle Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Embolization Particle Sales by Application (2021-2026) & (K Units) Table 70. Latin America Embolization Particle Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Embolization Particle Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Embolization Particle Sales by Application (2021-2026) & (US$ Million) Table 73. Sirtex Medical Company Information Table 74. Sirtex Medical Business Overview Table 75. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Sirtex Medical Embolization Particle Product Portfolio Table 77. Sirtex Medical Recent Development Table 78. Merit Medical Company Information Table 79. Merit Medical Business Overview Table 80. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Merit Medical Embolization Particle Product Portfolio Table 82. Merit Medical Recent Development Table 83. Cook Medical Company Information Table 84. Cook Medical Business Overview Table 85. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Cook Medical Embolization Particle Product Portfolio Table 87. Cook Medical Recent Development Table 88. BTG Medical Company Information Table 89. BTG Medical Business Overview Table 90. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. BTG Medical Embolization Particle Product Portfolio Table 92. BTG Medical Recent Development Table 93. Boston Scientific Corporation Company Information Table 94. Boston Scientific Corporation Business Overview Table 95. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Boston Scientific Corporation Embolization Particle Product Portfolio Table 97. Boston Scientific Corporation Recent Development Table 98. Terumo Corporation Company Information Table 99. Terumo Corporation Business Overview Table 100. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Terumo Corporation Embolization Particle Product Portfolio Table 102. Terumo Corporation Recent Development Table 103. HENGRUI Medical Company Information Table 104. HENGRUI Medical Business Overview Table 105. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. HENGRUI Medical Embolization Particle Product Portfolio Table 107. HENGRUI Medical Recent Development Table 108. INterface BIOmaterials B.V. Company Information Table 109. INterface BIOmaterials B.V. Business Overview Table 110. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. INterface BIOmaterials B.V. Embolization Particle Product Portfolio Table 112. INterface BIOmaterials B.V. Recent Development Table 113. Alicon Company Information Table 114. Alicon Business Overview Table 115. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Alicon Embolization Particle Product Portfolio Table 117. Alicon Recent Development Table 118. North America Embolization Particle Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Embolization Particle Sales by Country (2021-2026) & (K Units) Table 120. North America Embolization Particle Sales Market Share by Country (2021-2026) Table 121. North America Embolization Particle Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Embolization Particle Sales Market Share Forecast by Country (2027-2032) Table 123. North America Embolization Particle Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Embolization Particle Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Embolization Particle Market Share by Country (2021-2026) Table 126. North America Embolization Particle Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Embolization Particle Market Share Forecast by Country (2027-2032) Table 128. Europe Embolization Particle Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Embolization Particle Sales by Country (2021-2026) & (K Units) Table 130. Europe Embolization Particle Sales Market Share by Country (2021-2026) Table 131. Europe Embolization Particle Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Embolization Particle Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Embolization Particle Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Embolization Particle Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Embolization Particle Market Share by Country (2021-2026) Table 136. Europe Embolization Particle Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Embolization Particle Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Embolization Particle Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Embolization Particle Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Embolization Particle Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Embolization Particle Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Embolization Particle Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Embolization Particle Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Embolization Particle Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Embolization Particle Market Share by Country (2021-2026) Table 146. Asia-Pacific Embolization Particle Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Embolization Particle Market Share Forecast by Country (2027-2032) Table 148. Latin America Embolization Particle Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Embolization Particle Sales by Country (2021-2026) & (K Units) Table 150. Latin America Embolization Particle Sales Market Share by Country (2021-2026) Table 151. Latin America Embolization Particle Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Embolization Particle Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Embolization Particle Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Embolization Particle Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Embolization Particle Market Share by Country (2021-2026) Table 156. Latin America Embolization Particle Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Embolization Particle Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Embolization Particle Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Embolization Particle Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Embolization Particle Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Embolization Particle Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Embolization Particle Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Embolization Particle Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Embolization Particle Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Embolization Particle Market Share by Country (2021-2026) Table 166. Middle East and Africa Embolization Particle Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Embolization Particle Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Embolization Particle Distributors List Table 171. Embolization Particle Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Embolization Particle Image Figure 2. Global Embolization Particle Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Embolization Particle Market Size (2021-2032) & (US$ Million) Figure 4. Global Embolization Particle Sales (2021-2032) & (K Units) Figure 5. Microspheres Image Figure 6. Global Microspheres Sales YoY Growth (2021-2032) & (K Units) Figure 7. Particles (e.g. PVA Particles, Gelfoam Particles) Image Figure 8. Global Particles (e.g. PVA Particles, Gelfoam Particles) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Drug-eluting Beads (DEBs) Image Figure 10. Global Drug-eluting Beads (DEBs) Sales YoY Growth (2021-2032) & (K Units) Figure 11. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Image Figure 12. Global Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Embolization Particle Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Embolization Particle Market Share by Type 2025 VS 2032 Figure 15. North America Embolization Particle Sales Market Share in Volume by Type in 2025 Figure 16. North America Embolization Particle Sales Market Share in Value by Type in 2025 Figure 17. Europe Embolization Particle Sales Market Share in Volume by Type in 2025 Figure 18. Europe Embolization Particle Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Embolization Particle Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Embolization Particle Sales Market Share in Value by Type in 2025 Figure 21. Latin America Embolization Particle Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Embolization Particle Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Embolization Particle Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Embolization Particle Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Embolization Particle Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Uterine Fibroid Embolization Image Figure 28. Global Uterine Fibroid Embolization Sales YoY Growth (2021-2032) & (K Units) Figure 29. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Image Figure 30. Global Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Sales YoY Growth (2021-2032) & (K Units) Figure 31. Liver Tumor Embolization Image Figure 32. Global Liver Tumor Embolization Sales YoY Growth (2021-2032) & (K Units) Figure 33. Trauma Embolization Image Figure 34. Global Trauma Embolization Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Embolization Particle Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Embolization Particle Market Share by Application 2025 VS 2032 Figure 39. North America Embolization Particle Sales Market Share in Volume by Application in 2025 Figure 40. North America Embolization Particle Sales Market Share in Value by Application in 2025 Figure 41. Europe Embolization Particle Sales Market Share in Volume by Application in 2025 Figure 42. Europe Embolization Particle Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Embolization Particle Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Embolization Particle Sales Market Share in Value by Application in 2025 Figure 45. Latin America Embolization Particle Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Embolization Particle Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Embolization Particle Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Embolization Particle Sales Market Share in Value by Application in 2025 Figure 49. North America Embolization Particle Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Embolization Particle Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Embolization Particle Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Embolization Particle Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Embolization Particle Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Embolization Particle Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Embolization Particle Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Embolization Particle Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Embolization Particle Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Embolization Particle Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Embolization Particle Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Embolization Particle Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Embolization Particle Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Embolization Particle Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Embolization Particle Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Embolization Particle Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Embolization Particle Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Microspheres
  • Particles (e.g. PVA Particles, Gelfoam Particles)
  • Drug-eluting Beads (DEBs)
  • Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Applications
  • Uterine Fibroid Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Liver Tumor Embolization
  • Trauma Embolization
  • Others
Companies covered
  • Sirtex Medical
  • Merit Medical
  • Cook Medical
  • BTG Medical
  • Boston Scientific Corporation
  • Terumo Corporation
  • HENGRUI Medical
  • INterface BIOmaterials B.V.
  • Alicon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Embolization Particle Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Embolization Particle Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Embolization Particle Market by Type
  6. 1.3.1 Microspheres
  7. 1.3.2 Particles (e.g. PVA Particles, Gelfoam Particles)
  8. 1.3.3 Drug-eluting Beads (DEBs)
  9. 1.3.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
  10. 1.4 Global Embolization Particle Market Size by Type
  11. 1.4.1 Global Embolization Particle Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Embolization Particle Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Embolization Particle Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Embolization Particle Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Embolization Particle Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Embolization Particle Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Embolization Particle Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Embolization Particle Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Embolization Particle Industry Trends
  2. 2.2 Embolization Particle Industry Drivers
  3. 2.3 Embolization Particle Industry Opportunities and Challenges
  4. 2.4 Embolization Particle Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Embolization Particle Revenue (2021-2026)
  2. 3.2 Global Top Players by Embolization Particle Sales (2021-2026)
  3. 3.3 Global Top Players by Embolization Particle Price (2021-2026)
  4. 3.4 Global Embolization Particle Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Embolization Particle Major Company Production Sites & Headquarters
  6. 3.6 Global Embolization Particle Company, Product Type & Application
  7. 3.7 Global Embolization Particle Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Embolization Particle Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Embolization Particle Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Embolization Particle Tier 1, Tier 2, and Tier 3
4 Embolization Particle Regional Status and Outlook
  1. 4.1 Global Embolization Particle Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Embolization Particle Historic Market Size by Region
  3. 4.2.1 Global Embolization Particle Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Embolization Particle Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Embolization Particle Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Embolization Particle Forecasted Market Size by Region
  7. 4.3.1 Global Embolization Particle Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Embolization Particle Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Embolization Particle Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Embolization Particle by Application
  1. 5.1 Embolization Particle Market by Application
  2. 5.1.1 Uterine Fibroid Embolization
  3. 5.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  4. 5.1.3 Liver Tumor Embolization
  5. 5.1.4 Trauma Embolization
  6. 5.1.5 Others
  7. 5.2 Global Embolization Particle Market Size by Application
  8. 5.2.1 Global Embolization Particle Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Embolization Particle Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Embolization Particle Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Embolization Particle Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Embolization Particle Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Embolization Particle Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Embolization Particle Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Embolization Particle Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sirtex Medical
  2. 6.1.1 Sirtex Medical Company Information
  3. 6.1.2 Sirtex Medical Business Overview
  4. 6.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sirtex Medical Embolization Particle Product Portfolio
  6. 6.1.5 Sirtex Medical Recent Developments
  7. 6.2 Merit Medical
  8. 6.2.1 Merit Medical Company Information
  9. 6.2.2 Merit Medical Business Overview
  10. 6.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merit Medical Embolization Particle Product Portfolio
  12. 6.2.5 Merit Medical Recent Developments
  13. 6.3 Cook Medical
  14. 6.3.1 Cook Medical Company Information
  15. 6.3.2 Cook Medical Business Overview
  16. 6.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cook Medical Embolization Particle Product Portfolio
  18. 6.3.5 Cook Medical Recent Developments
  19. 6.4 BTG Medical
  20. 6.4.1 BTG Medical Company Information
  21. 6.4.2 BTG Medical Business Overview
  22. 6.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BTG Medical Embolization Particle Product Portfolio
  24. 6.4.5 BTG Medical Recent Developments
  25. 6.5 Boston Scientific Corporation
  26. 6.5.1 Boston Scientific Corporation Company Information
  27. 6.5.2 Boston Scientific Corporation Business Overview
  28. 6.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
  30. 6.5.5 Boston Scientific Corporation Recent Developments
  31. 6.6 Terumo Corporation
  32. 6.6.1 Terumo Corporation Company Information
  33. 6.6.2 Terumo Corporation Business Overview
  34. 6.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Terumo Corporation Embolization Particle Product Portfolio
  36. 6.6.5 Terumo Corporation Recent Developments
  37. 6.7 HENGRUI Medical
  38. 6.7.1 HENGRUI Medical Company Information
  39. 6.7.2 HENGRUI Medical Business Overview
  40. 6.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 HENGRUI Medical Embolization Particle Product Portfolio
  42. 6.7.5 HENGRUI Medical Recent Developments
  43. 6.8 INterface BIOmaterials B.V.
  44. 6.8.1 INterface BIOmaterials B.V. Company Information
  45. 6.8.2 INterface BIOmaterials B.V. Business Overview
  46. 6.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
  48. 6.8.5 INterface BIOmaterials B.V. Recent Developments
  49. 6.9 Alicon
  50. 6.9.1 Alicon Company Information
  51. 6.9.2 Alicon Business Overview
  52. 6.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alicon Embolization Particle Product Portfolio
  54. 6.9.5 Alicon Recent Developments
7 North America by Country
  1. 7.1 North America Embolization Particle Sales by Country
  2. 7.1.1 North America Embolization Particle Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Embolization Particle Sales by Country (2021-2026)
  4. 7.1.3 North America Embolization Particle Sales Forecast by Country (2027-2032)
  5. 7.2 North America Embolization Particle Market Size by Country
  6. 7.2.1 North America Embolization Particle Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Embolization Particle Market Size by Country (2021-2026)
  8. 7.2.3 North America Embolization Particle Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Embolization Particle Sales by Country
  2. 8.1.1 Europe Embolization Particle Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Embolization Particle Sales by Country (2021-2026)
  4. 8.1.3 Europe Embolization Particle Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Embolization Particle Market Size by Country
  6. 8.2.1 Europe Embolization Particle Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Embolization Particle Market Size by Country (2021-2026)
  8. 8.2.3 Europe Embolization Particle Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Embolization Particle Sales by Country
  2. 9.1.1 Asia-Pacific Embolization Particle Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Embolization Particle Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Embolization Particle Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Embolization Particle Market Size by Country
  6. 9.2.1 Asia-Pacific Embolization Particle Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Embolization Particle Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Embolization Particle Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Embolization Particle Sales by Country
  2. 10.1.1 South America Embolization Particle Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Embolization Particle Sales by Country (2021-2026)
  4. 10.1.3 South America Embolization Particle Sales Forecast by Country (2027-2032)
  5. 10.2 South America Embolization Particle Market Size by Country
  6. 10.2.1 South America Embolization Particle Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Embolization Particle Market Size by Country (2021-2026)
  8. 10.2.3 South America Embolization Particle Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Embolization Particle Sales by Country
  2. 11.1.1 Middle East and Africa Embolization Particle Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Embolization Particle Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Embolization Particle Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Embolization Particle Market Size by Country
  6. 11.2.1 Middle East and Africa Embolization Particle Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Embolization Particle Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Embolization Particle Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Embolization Particle Value Chain Analysis
  2. 12.1.1 Embolization Particle Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Embolization Particle Production Mode & Process
  7. 12.2 Embolization Particle Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Embolization Particle Distributors
  10. 12.2.3 Embolization Particle Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst